Gain Therapeutics, Inc. Successfully completed GLP toxicology studies for lead program GT-02287 in GBA1 Parkinsons disease Company is on track to submit application for start of Phase 1 clinical trial of GT-02287 to the Human Research Ethics Committee (HREC) in Australia in mid-2023 Received a $2.8 million (CHF $2.5 million) grant from Innosuisse, the Swiss Innovation Agency, to advance the development of GT-02287 in GBA1 Parkinsons disease Obtained a grant in the aggregate amount of $1.3 million (EUR 1.2 million) to a consortium led by Gain Therapeutics for further development of the Companys novel small molecule allosteric regulators against Alpha-1 Antitrypsin Deficiency Appointed C. Continue reading →

Understanding Movement Disorders: All About Parkinson's Disease, Essential Tremor and Dystonia Movement disorders like Parkinson's disease, tremors and dystonia affect the brain, spine and nerves, causing abnormal, slow or limited movement. For those who have been diagnosed with a movement disorder, everyday tasks can become incredibly difficult and make you feel like you've lost control over certain parts of your life Continue reading →

Lorna E. Thorpe, PhD, MPH Recently published data from electronic health records of more than 2.2 million Americans with COVID-19 showed that adults with obstructive sleep apnea (OSA) were more likely to experience long-term symptoms suggestive of long COVID than those without the sleep disorder. No significant links were identified in children after controlling for other medical conditions, including obesity Continue reading →

Matt Baron/BEI/Shutterstock After nearly 35 years of marriage,Michael J. Continue reading →

WATCH TIME: 3 minutes "Prevention medicines dont discriminate between the two [aura vs nonaura]. Continue reading →

Introduction In late 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) led to a global pandemic of coronavirus disease 2019 (COVID-19). The infectious coronavirus leads to a severe respiratory syndrome and potentially to neurological disorders.1 Older people with comorbidities, including diabetes mellitus, cardiac failure, and respiratory disease, are at increased risk for serious COVID-19 illness. Parkinsons disease (PD) is more prevalent in older people who are often frail and have comorbidities; therefore, elderly patients with PD could be at risk of severe COVID-19 disease.1,2 Many countries implemented lockdowns and social distancing to control the COVID-19 pandemic. Continue reading →